A detailed history of Cable Car Capital LLC transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Cable Car Capital LLC holds 145,000 shares of GANX stock, worth $329,150. This represents 0.2% of its overall portfolio holdings.

Number of Shares
145,000
Holding current value
$329,150
% of portfolio
0.2%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.24 - $3.99 $179,800 - $578,550
145,000 New
145,000 $186 Million

Others Institutions Holding GANX

About Gain Therapeutics, Inc.


  • Ticker GANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,883,400
  • Market Cap $27M
  • Description
  • Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...
More about GANX
Track This Portfolio

Track Cable Car Capital LLC Portfolio

Follow Cable Car Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Car Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Car Capital LLC with notifications on news.